We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Molecular Platform Evaluated for Yeast Infected Blood

By LabMedica International staff writers
Posted on 12 Mar 2012
A polymerase chain reaction (PCR) protocol has been optimized that will detect low numbers of yeasts in small volumes of simulated and clinical specimens.

An innovative microfluidic real-time PCR platform was evaluated for the diagnosis of invasive candidiasis and has the potential for full automation and rapid turnaround. More...


Scientists at Duke University Medical Center (Durham, NC, USA) selected samples from patients with positive blood cultures for species of Candida as well as many blood culture-negative controls. Of particular interest were 16 banked blood specimens suspected to harbor C. albicans DNA for comparative testing on conventional and microfluidic real-time PCR platforms. Each of the 16 PCR-tested blood specimens was collected within 24 hours of a specimen from the same patient that later became culture-positive for C. albicans.

Eleven and nine of 16 specimens from individual patients with culture-proven candidemia tested positive for C. albicans DNA by conventional and microfluidic real-time PCR, respectively, for a combined sensitivity of 94%. Using simulated specimens, the investigators optimized the extraction protocol to detect five colony-forming units (CFU) of C. albicans in 500 µL blood; however, testing low CFU in small blood volumes confirmed this procedure to be stochastic. This problem could be ameliorated by sampling at least 1.0 mL blood and/or performing multiple tests.

The digital microfluidic platform for real-time PCR, pioneered by Advanced Liquid Logic, Inc. (Research Triangle Park, NC, USA), has the potential to revolutionize the diagnosis of infectious diseases by offering rapid, automated, economical, and point-of-care detection of pathogenic DNA in clinical samples. The authors concluded that the ideal diagnostic PCR test should be minimally invasive, specific, and sensitive, provide early detection, and amenable to frequent testing. The assay should be effective with minimal sample sizes, and predictive of infection in the target population. It should allow quantification, identification of multiple pathogens, have a low cost, and not require special expertise to perform. They believe that the digital microfluidic real-time PCR platform is on track to satisfy all of these criteria.

Related Links:

Duke University Medical Center
Advanced Liquid Logic



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.